Sherwin-Williams (SHW) reported Q2 2025 earnings of $3.38 per share, significantly missing the Zacks Consensus Estimate of $3.76 by 10.11% and falling below $3.70 from a year ago. While the company's revenues of $6.31 billion slightly surpassed consensus estimates, this earnings miss, coupled with the stock's year-to-date underperformance (up 0.4% vs. S&P 500's 7.2% gain), places increased importance on management's commentary during the upcoming earnings call to dictate future share price movement.
Sherwin-Williams (SHW) reported a significant earnings miss for the quarter ended June 2025, with adjusted EPS of $3.38 falling 10.11% short of the $3.76 consensus estimate and declining from $3.70 in the prior-year period. This considerable profit shortfall overshadows a marginal revenue beat, where the reported $6.31 billion was just 0.49% above estimates and represented tepid year-over-year growth from $6.27 billion. The company's performance has been inconsistent, having surpassed EPS estimates in only two of the last four quarters. This disappointing result compounds the stock's existing market underperformance, with a year-to-date gain of only 0.4% versus the S&P 500's 7.2% advance. While the company operates within a favorably ranked industry (Zacks Chemical - Specialty, top 32%), the current Zacks Rank #3 (Hold) and mixed pre-earnings estimate revisions suggest a neutral outlook. The stock's near-term direction is now heavily dependent on management's forthcoming commentary and guidance, which will be crucial for assessing whether margin pressures are intensifying.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment